Eli Lilly's obesity empire

Statements (5)

1. ● Neutral

   Eli Lilly CEO reveals shift in GLP-1 pill market

   thestreet.comSep 22, 2026 19:17 UTC
2. ▲ Bullish

   Eli Lilly's Foundayo gained market share in the weight-loss pill market

   breakingthenews.netSep 21, 2026 18:05 UTC
3. ▲ Bullish

   Eli Lilly is developing a weight loss drug for every type of patient

   finance.yahoo.comAug 15, 2026 18:20 UTC
4. ▲ Bullish

   Eli Lilly's diabetes and obesity drugs exceeded expectations in recent sales

   investors.comAug 5, 2026 12:56 UTCHigh importance
5. ▲ Bullish

   Eli Lilly is set to ride the peptide wave in the wellness market.

   investors.comJul 24, 2026 15:40 UTC